210 top medical experts on Pseudoangiomatous stromal hyperplasia across 21 countries and 17 U.S. states, including 62 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pseudoangiomatous stromal hyperplasia: Pseudoangiomatous stromal hyperplasia (PASH) is a type of non-cancerous breast lesion. It typically affects women in the reproductive age group.Occasional cases have been described in men, postmenopausal women, adolescents, and children.The size of the lesion varies, but small microscopic PASH is much more common than larger (tumorous) masses. Microscopic PASH is often an incidental finding in breast biopsies done for other non-cancerous or cancerous lesions. Tumorous PASH presents as a firm, painless breast mass or a dense region on a mammogram .The underlying cause of PASH is unclear. There is some evidence in the literature to suggest that hormonal factors may play a role. While PASH itself is benign, it may mimic cancer (specifically angiosarcoma). For this reason, a biopsy may be recommended. Treatment may include observation or surgical excision.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations
  4. Synonyms: Mammary pseudoangiomatous stromal hyperplasia,  Pseudoangiomatous stromal hyperplasia of the breast


  

        

                    


    Computing Expert Listing ...